| 000 | 01824 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250514004017.0 | ||
| 264 | 0 | _c20010920 | |
| 008 | 200109s 0 0 eng d | ||
| 022 | _a0168-0102 | ||
| 024 | 7 |
_a10.1016/s0168-0102(01)00242-5 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPark, K W | |
| 245 | 0 | 0 |
_aProtection of nigral neurons by GDNF-engineered marrow cell transplantation. _h[electronic resource] |
| 260 |
_bNeuroscience research _cAug 2001 |
||
| 300 |
_a315-23 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBehavior, Animal _xphysiology |
| 650 | 0 | 4 |
_aBone Marrow Cells _xcytology |
| 650 | 0 | 4 |
_aBone Marrow Transplantation _xmethods |
| 650 | 0 | 4 |
_aCells, Cultured _xcytology |
| 650 | 0 | 4 |
_aDNA, Complementary _xgenetics |
| 650 | 0 | 4 |
_aDopamine _xbiosynthesis |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGenetic Therapy _xmethods |
| 650 | 0 | 4 | _aGenetic Vectors |
| 650 | 0 | 4 | _aGlial Cell Line-Derived Neurotrophic Factor |
| 650 | 0 | 4 | _aImmunohistochemistry |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Inbred C57BL |
| 650 | 0 | 4 |
_aMotor Activity _xgenetics |
| 650 | 0 | 4 | _aNerve Growth Factors |
| 650 | 0 | 4 |
_aNerve Tissue Proteins _xbiosynthesis |
| 650 | 0 | 4 |
_aNeurons _xdrug effects |
| 650 | 0 | 4 |
_aNeuroprotective Agents _xmetabolism |
| 650 | 0 | 4 |
_aParkinsonian Disorders _xgenetics |
| 650 | 0 | 4 |
_aRecovery of Function _xgenetics |
| 650 | 0 | 4 |
_aSubstantia Nigra _xdrug effects |
| 650 | 0 | 4 |
_aTransfection _xmethods |
| 650 | 0 | 4 |
_aTyrosine 3-Monooxygenase _xbiosynthesis |
| 700 | 1 | _aEglitis, M A | |
| 700 | 1 | _aMouradian, M M | |
| 773 | 0 |
_tNeuroscience research _gvol. 40 _gno. 4 _gp. 315-23 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0168-0102(01)00242-5 _zAvailable from publisher's website |
| 999 |
_c11391378 _d11391378 |
||